Day: September 2, 2021

Relief Reports Regulatory Clearance in Germany to Commence a Multicenter, Double-blind, Randomized Phase 2 Clinical Trial to Evaluate Inhaled Aviptadil for the Treatment of Sarcoidosis

GENEVA, SWITZERLAND / ACCESSWIRE / September 2, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company seeking to...

BehaVR Announces NurtureVR, First Virtual Reality Program Aimed to Lower Stress, Anxiety and Fear for Pregnant Women, Now Suffering at Record Levels Due to Ongoing Pandemic

NASHVILLE, Tenn., Sept. 1, 2021 /PRNewswire/ -- BehaVR today announced its direct-to-consumer launch of NurtureVR, a first-of-its-kind program to liberate expectant mothers...

error: Content is protected !!